MF
HARP

Manchester Financial’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Manchester Financial’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20
Closed -$4K – 718
2021
Q1 		$4K Hold
20
– – ﹤0.01% 585
2020
Q4 		$3K Hold
20
– – ﹤0.01% 524
2020
Q3 		$3K Hold
20
– – ﹤0.01% 473
2020
Q2 		$3K Hold
20
– – ﹤0.01% 444
2020
Q1 		$2K Hold
20
– – ﹤0.01% 451
2019
Q4 		$3K Buy
+20
New +$3.03K ﹤0.01% 485

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Manchester Financial's HARP Position: Q2 2021 in Review

Manchester Financial sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2021, closing a stake of 20 shares — an estimated $4K sold.

Manchester Financial first reported a position in HARP in Q4 2019 and held it in 6 quarters. The position peaked at $4K in Q1 2021. 85 funds tracked by Wall St. Rank hold HARP as of Q2 2021.

  • Manchester Financial reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 20 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $4K.
  • Manchester Financial first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • Manchester Financial's Harpoon Therapeutics, Inc. Common Stock position peaked at $4K in Q1 2021.
  • 85 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.